Immunization in Europe

Vaccines

Volumn , Issue , 2008, Pages 1511-1524

  Salisbury, David M ^a   Spika, John S ^b  

^a Department of Health ^*  (United Kingdom)

^b WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85159030638     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3611-1.50072-6     Document Type: Chapter

References (95)

1. The health for all policy framework for the WHO European Region Copenhagen, WHO Regional Office for Europe, 1999 (European Health for All Series, No.6), pp. 43–54. Online. Available at://www.euro.who.int/InformationSources/Publications/Catalogue/20010911_38 Accessed 24 August 2006.
2. Surveillance guidelines for measles and congenital rubella infection in the WHO European Region Copenhagen, WHO Regional Office for Europe, 2003. Online. Available at: http://www.euro.who.int/document/E82183.pdf Accessed 24 August 2006.
3. Computerized Information System for Infectious Diseases (CISID). Copenhagen, World Health Organization Regional Office for Europe. Online. Available at: data.euro.who.int/cisid/ Accessed 28 August 2006.
4. CR Vitek and M Wharton (1998) Diphtheria in the former Soviet Union: re-emergence of a pandemic disease. Emerg Infect Dis 4 539-550.
5. Measles outbreak in the Ukraine, 2005–2006, JS Spika, C Aidyralieva, L Mukharskaya, NN Kostyuchenko, M Mulders, G Lipskaya, N Emiroglu. Online. Available at: http://www.eurosurveillance.org/ew/2006/060309.asp Accessed 28 August 2006
6. Immunization Standards—National Regulatory Authorities World Health Organization. Online. Available at: http://www.who.int/immunization_standards/national_regulatory_authorities%20/role/en/index.html/ Accessed 27 August 2006
7. Immunization standards—vaccine quality World Health Organization. Online. Available at: http://www.who.int/immunization_standards/vaccine_quality/vq_index/en/index.html Accessed 27 August 2006
8. Decision No 2119/98/EC of the European Parliament and of the Council of 24 September 1998, setting up a network for the epidemiological surveillance and control of communicable diseases in the Community. Online. Available at: europa.eu.int/eur-lex/pri/en/oj/dat/1998/l_268/l_26819981003en00010006.pdf#search=%22Decision%20No%202119%2F98%2FEC%20of%20the%20European%20Parliament%20and%20of%20the%20Council%20of%2024%20September%201998%22 Accessed 28 September.
9. Surveillance Community Network for Vaccine Preventable Infectious Diseases Online. Available at: ec.europa.eu/health/ph_threats/com/networks/network_euvac_en.htm Accessed 28 September 2006.
10. K Osborne, J Weinberg and E Miller The European Sero-Epidemiology Network. Euro Surveill 2(4):29–31, 1997. Online. Available at: http://www.eurosurveillance.org/em/v02n04/0204-223.asp Accessed 03 October 2006
11. Regulation (EC) No 851/2004 of the European Parliament and of the Council of 21 April 2004 establishing a European Centre for disease prevention and control. Official J European Union L 142 1.
12. European Centre for Disease Prevention and Control Online. Available at: http://www.ecdc.eu.int Accessed 24 August 2006.
13. N Guérin and C Roure Immunisation schedules in the countries of the European Union. Euro Surveill 0(0):5–7, 1995. Online. Available at: www.eurosurveillance.org/em/v00n00/0000-224.asp Accessed 03 October 2006.
14. N Guérin and C Roure Immunisation coverage in the European Union. Euro Surveill 2(1):2–4, 1997. Online. Available at: www.eurosurveillance.org/em/v02n01/0201-222.asp Accessed 03 October 2006.
15. WHO Vaccine Preventable Diseases Monitoring System Immunization surveillance, assessment and monitoring; data, statistics and graphs. Online. Available at: www.who.int/immunization_monitoring/en/globalsummary/countryprofileselect.cfm Accessed 28 August 2006.
16. Immunization schedules by antigen, selection centre Online. Available at: www.who.int/immunization_monitoring/en/globalsummary/scheduleselect.cfm Accessed 26 August 2006.
17. EUVAC NET. A surveillance community network for vaccine preventable infectious diseases. Childhood vaccination schedule. Online. Available at: www.euvac.net/graphics/html/EUVAC/index.html Accessed 28 September 2006.
18. Eliminating measles and rubella and prevention congenital rubella infection, WHO European Region strategic plan 2005–2010. Copenhagen, WHO Regional Office for Europe, 2005. ISBN 92 890 1382 6. Online. Available at: www.euro.who.int/document/E87772.pdf Accessed 28 September 2006.
19. CL Trotter, ME Ramsay and MP Slack (2003) Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health 6(1), 55-58.
20. J McVernon, N Andrews, MP Slack and ME Ramsay (2003) Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 361(9368), 1521-1523.
21. Hib booster Added protection planned against Hib Booster vaccine to be offered following increase in cases. Online. Available at: www.immunisation.nhs.uk/article.php?id=417 Accessed 15 September 2006.
22. Pneumococcal vaccine added to the childhood immunisation programme; more protection against meningitis and septicaemia Online. Available at: www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressReleasesNotices/fs/en?CONTENT_ID=4128036&chk=PI8e57 Accessed 15 September 2006.
23. Important changes to the childhood immunisation programme Online. Available at: www.dh.gov.uk/assetRoot/04/13/71/75/04137175.pdf Accessed 28 September 2006.
24. Strategic plan for measles and congenital rubella infection in the European Region of WHO Copenhagen, WHO Regional Office for Europe, 2003. Online. Available at: www.euro.who.int/document/e81567.pdf Accessed 28 September 2006.
25. Strengthening national immunization systems through measles and rubella elimination and prevention of congenital rubella infections in WHO's European Region. Resolution EUR/RC55/R7 of the WHO Regional Committee for Europe, fifty-fifth session, 2005. WHO Regional Office for Europe, 2005.
26. FX Hanon, JS Spika, MN Mulders, et al. Progress toward elimination of measles and prevention of congenital rubella infection—European Region, 1990–2004. MMWR 54(7):175–178, 2005. Online. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5407a5.htm Accessed 3 October 2005.
27. JM Best, C Castillo-Solorzano, JS Spika, et al. (2005) Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee on Research related to Measles and Rubella Vaccine and Vaccination, June 2004. J Infect Dis 192(11), 1890-1897.
28. Certification of Poliomyelitis Eradication Fifteenth meeting of the European Regional Certification Commission, Copenhagen 19–21 June 2002. Copenhagen, World Health Organization. 2005. Online. Available at: www.euro.who.int/Document/E88105.pdf Accessed 3 October 2006.
29. National Laboratory Inventory for Global Poliovirus Containment—European Region, June 2006. MMWR 2006; 55(33);916–18. Online. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5533a3.html Accessed 28 September 2006.
30. AJ Wakefield, RM Pittilo and R Sim (1993) Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 39 345-353.
31. AJ Wakefield, A Ekbom, AP Dhillon, et al. (1995) Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 108 911-916.
32. NP Thompson, SM Montgomery, RE Pounder and AJ Wakefield (1995) Is measles a risk factor for inflammatory bowel disease? Lancet 345 1071-1074.
33. NP Thompson, RE Pounder and AJ Wakefield (1995) Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol 7 385-390.
34. A Ekbom, P Daszak, W Kraaz and AJ Wakefield (1996) Crohn's disease after in-utero measles virus exposure. Lancet 348 515-517.
35. P Daszak, M Purcell, J Lewin, et al. (1997) Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy. J Clin Pathol 50 299-304.
36. M Iizuka, O Nakagomi, M Chiba, et al. (1995) Absence of measles virus in Crohn's disease. Lancet 345 199.
37. P Minor (1995) Measles vaccination as a risk factor for inflammatory bowel disease. Lancet 345 1362-1363.
38. P Farrington and E Miller (1995) Measles vaccination as a risk factor for inflammatory bowel disease. Lancet 345 1362.
39. T MacDonald (1995) Measles vaccination as a risk factor for inflammatory bowel disease. Lancet 345 1363.
40. Y Haga, O Funakoshi, K Kuroe, et al. (1996) Absence of measles vital genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 38 211-215.
41. M Iizuka and O Masamune (1997) Measles vaccination and inflammatory bowel disease. Lancet 350 1775.
42. M Feeney, A Ciegg, P Winwood and J Snook (1997) A case control study of measles vaccination and inflammatory bowel disease. Lancet 350 764-766.
43. P Jones, P Fine and S Piracha (1997) Crohn's disease and measles. Lancet 349 473.
44. MA Afzal, PD Minor, J Begley, et al. (1998) Absence of measles-virus genome in inflammatory bowel disease. Lancet 351 646. 467
45. N Chadwick, IJ Bruce, S Schepelmann, et al. (1998) Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. J Med Virol 55 305-311.
46. E Miller and R Waight (1998) Second immunisation has not affected IBD incidence in England. BMJ 316 1745.
47. RG Pebody, M Paunio and P Ruutu (1998) Crohn's disease has not increased in Finland. BMJ 316 1745.
48. LL Nielsen, NM Nielsen, M Melbye, et al. (1998) Exposure to measles in utero and Crohn's disease: Danish register study. BMJ 316 196-197.
49. R Lawrenson and R Farmer (1998) Age-specific prevalences do not suggest association with in utero exposure. BMJ 316 1746.
50. MA Afzal, E Armitage, S Ghosh, et al. (2000) Further evidence of absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease. J Med Virol 62 377-382.
51. M Iizuka, M Chiba, M Yukawa, et al. (2000) Immunohistochemical analysis of the distribution of measles-related antigen in the intestinal mucosa in IBD. Gut 46 163-169.
52. RL Davis, P Kramarz, K Bohlke, et al. (2001) Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease. Arch Pediatr Adolesc Med 155 354-359.
53. Editor's Choice (1998) BMJ 316(7133), 715-716.
54. A Wakefield, SH Murch, A Anthony, et al. (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351 637-641.
55. C Gillberg and H Heijbel (1998) MMR and autism. Autism 2 423-424.
56. H Peltola, A Patja, P Leinkki, et al. (1998) No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 351 1327-1328.
57. B Taylor, E Miller, CP Farrington, et al. (1999) Autism and measles, mumps and rubella: no epidemiological evidence for a causal association. Lancet 353 2026-2029.
58. E Fombonne and S Chakrabarti (2001) No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 108(suppl 4), E58.
59. C. Medical Research Council MRC Review of Autism Research: Epidemiology and Causes. London, Medical Research Council, 2001. Online. Available at: www.mrc.ac.uk/pdf-autism-report.pdf Accessed 28 September 2006.
60. L Dales, SJ Hammer and NJ Smith (2001) Time trends in autism and in MMR immunization coverage in California. JAMA 285 1183-1185.
61. CP Farrington, E Miller and B Taylor (2001) MMR and autism: further evidence against a causal association. Vaccine 19 3632-3665.
62. M Gershon (2002) Autism and the measles-mumps-rubella (MMR) vaccine. Rev Vacunas 2 156-157.
63. B Taylor, E Miller, R Lingam, et al. (2002) Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 324 393-396.
64. KM Madsen, A Hviid, M Vestergaard, et al. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347 1477-1482.
65. A Mäkelä, P Nuorti and H Peltola (2002) Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110 957-963.
66. L Smeeth, C Cook, E Fombonne, et al. (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364(9438), 963-999.
67. V Uhlmann, CM Martin, O Sheils, et al. (2002) Potential viral pathogenic mechanism for new variant inflammatory bowel disease. J Clin Pathol Mol Pathol 55 84-90.
68. ME Ramsay, J Yarwood, D Lewis, et al. (2002) Parental confidence in measles, mumps, and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract 52 912-916.
69. Effects of media reporting on MMR coverage. Commun Dis Rep CDR Wkly 12(35), 30.
70. MMR and autism investigation Online. Available at: briandeer.com/mmr-lancet.htm Accessed 28 September 2006.
71. I Hargreaves, J Lewis and T Speers Towards a better map: science, the public and the media. Online. Available at: www.esrcsocietytoday.ac.uk/ESRCInfoCentre/Images/Mapdocfinal_tcm6-5505.pdf Accessed 28 September 2006.
72. R Harrabin, A Coote and J Allen Health in the News: Risk, Reporting and Media Influence. September 2003 | ISBN 1857174801. Online. Available at: www.kingsfund.org.uk/news/press_releases/news_media.html Accessed 28 September 2006.
73. Measles notifications and confirmed cases, England and Wales 1995–2005, by quarter. Online. Available at: www.hpa.org.uk/infections/topics_az/measles/graph_conf_cases_qtr.htm Accessed 28 September 2006.
74. Outbreak of measles in Doncaster CDR Weekly 16(15), 2006. Online. Available at: www.hpa.org.uk/cdr/archives/archive06/News/news1506.htm#measles Accessed 12 September 2006.
75. F. MMR The Facts Online. Available at: www.mmrthefacts.nhs.uk/ Accessed 12 September 2006.
76. A Siedler, W Hellenbrand and G Rasch Measles outbreaks in Germany. Eurosurveillance 6(12):2002. Online. Available at: www.eurosurveillance.org/ew/2002/020321.asp Accessed 12 September 2006.
77. A Siedler, A Tischer, A Mankertz and S Santibanez Two outbreaks of measles in Germany. 2005. Euro Surveill 11(4):131–134, 2006. Online. Available at: www.eurosurveillance.org/em/v11n04/1104-225.asp Accessed 03 October 2006.
78. U van Treek Measles outbreak in Germany: over 1,000 cases now reported in Nordrhein Westfalen. Eurosurveillance 11(5), 2006. Online. Available at: www.eurosurveillance.org/ew/2006/060511.asp Accessed 03 October 2006.
79. The anthroposophical anti-vaccinators Online. Available at: www.blacktriangle.org/blog/?p=879 Accessed 12 September 2006.
80. Rudolf Steiner, Anthroposophical Leading Thoughts, 1904. Online. Available at: en.wikipedia.org/wiki/Anthroposophy Accessed 12 September 2006.
81. Dutch panic over polio outbreak Online. Available at: www.newscientist.com/article/mg13618411.600-dutch-panic-over-polio-outbreak-.html Accessed 14 September 2006.
82. PM Oostvogel, JK vanWijngaarden, HG van der Avoort, et al. (1994) Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992–93. Lancet 344(8923), 665-670.
83. MA Conyn-van Spaendonck, PM Oostvogel, AM van Loon, et al. (1996) Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992–1993. Am J Epidemiol 143(9), 929-935.
84. Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993. Appl Environ Microbiol 63(2), 519-523.
85. JE van Steen bergen, S vandenHof, MW Langendam, et al. (2000) Measles outbreak—Netherlands, April 1999–January 2000. MMWR 49(14), 299-303. Online. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm4914a2.htm Accessed 03 October 2006.
86. Y van der Veen, S Hahné, H Ruijs, et al. (2005) Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome. Eurosurveillance 10(11), Online. Available at: www.eurosurveillance.org/ew/2005/051124.asp#3 Accessed 03 October 2006.
87. Increase in measles cases in 2006, in England and Wales, 2006, CDR Weekly 16(12), 2006. Online. Available at: www.hpa.org.uk/cdr/archives/2006/cdr1206.pdf Accessed 03 October 2006.
88. Red de Vigilancia Epidemiológica de la Comunidad de Madrid Outbreak of rubella in the Madrid region, Spain, 2005. Eurosurveillance 10(7), 2005. Online. Available at: www.eurosurveillance.org/ew/2005/050707.asp Accessed 03 October 2006.
89. T Georgakopoulou, C Grylli, E Kalamara, et al. Current measles outbreak in Greece. Eurosurveillance 11(2), 2006. Online. Available at: www.eurosurveillance.org/ew/2006/060223.asp#2 Accessed 03 October 2006.
90. P Tookey (2004) Rubella in England. Scotland and Wales Euro Surveill 9(4), 21-23. Online. Available at: www.eurosurveillance.org/em/v09n04/0904-231.asp Accessed 03 October 2006.
91. International Centre for Migration Policy Development The scope and features of Roma irregular movements, the reactions of the host countries and the effects on the EU Candidate States. 2001 Vienna. Online. Available at: www.icmpd.org/uploadimg/Final%20ICMPD%20Odysseus%20Romareport%20March%202001.pdf Accessed 12 September 2006.
92. K Sepkowitz (2006) Health of the world's Roma population. Lancet 367 1707-1708.
93. Good information practices for vaccine safety websites Geneva, World Health Organization. Online. Available at: www.who.int/vaccine_safety/good_vs_sites/en/ Accessed 12 September 2006.
94. Vaccination and immunization information—Vaccine Safety Net Copenhagen, World Health Organization. Online. Available at: www.euro.who.int/vaccine/related/20040826_1 Accessed 12 September 2006.
95. W. European Immunization Week Copenhagen, World Health Organization. Online. Available at: www.euro.who.int/vaccine/20050608_1 Last Accessed 12 September 2006.